331 related articles for article (PubMed ID: 19183889)
1. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
Ansari MT; Iqbal I; Sunderland VB
Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
[TBL] [Abstract][Full Text] [Related]
2. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.
Ansari MT; Batty KT; Iqbal I; Sunderland VB
Arch Pharm Res; 2011 May; 34(5):757-65. PubMed ID: 21656361
[TBL] [Abstract][Full Text] [Related]
3. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
5. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
6. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
Yang B; Lin J; Chen Y; Liu Y
Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.
Awais S; Farooq N; Muhammad SA; El-Serehy HA; Ishtiaq F; Afridi M; Ahsan H; Ullah A; Nadeem T; Sultana K
Molecules; 2023 May; 28(9):. PubMed ID: 37175270
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
10. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
12. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
13. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
15. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
[TBL] [Abstract][Full Text] [Related]
16. Improved physicochemical characteristics of artemisinin using succinic acid.
Ansari MT; Pervez H; Shehzad MT; Saeed-ul-Hassan S; Mehmood Z; Shah SN; Razi MT; Murtaza G
Acta Pol Pharm; 2014; 71(3):451-62. PubMed ID: 25265825
[TBL] [Abstract][Full Text] [Related]
17. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
18. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
19. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and characterization of dihydroartemisinin/ hydroxypropyl-beta-cyclodextrin inclusion complex].
Chen FW; Guo T; Li HY; Guo Z; He ZG; Shi SL; Zhang JW
Yao Xue Xue Bao; 2012 Apr; 47(4):529-34. PubMed ID: 22799039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
